TD Asset Management
SNDX icon

TD Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

TD Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,760
Closed -$732K – 1424
2024
Q1 		$732K Hold
30,760
– – ﹤0.01% 1236
2023
Q4 		$665K Buy
+30,760
New +$473K ﹤0.01% 1260
2021
Q4 		– Sell
-28,671
Closed -$548K – 1540
2021
Q3 		$548K Hold
28,671
– – ﹤0.01% 1372
2021
Q2 		$418K Hold
28,671
– – ﹤0.01% 1410
2021
Q1 		$641K Buy
28,671
+18,571
+184% +$420K ﹤0.01% 1354
2020
Q4 		$225K Buy
+10,100
New +$209K ﹤0.01% 1416

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

TD Asset Management's SNDX Position: Q2 2024 in Review

TD Asset Management sold out of Syndax Pharmaceuticals (SNDX) in Q2 2024, closing a stake of 30,760 shares — an estimated $732K sold.

TD Asset Management first reported a position in SNDX in Q4 2020 and held it in 6 quarters. The position peaked at $732K in Q1 2024. 196 funds tracked by Wall St. Rank hold SNDX as of Q2 2024.

  • TD Asset Management reported no remaining Syndax Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • TD Asset Management sold 30,760 Syndax Pharmaceuticals shares in Q2 2024, an estimated $732K.
  • TD Asset Management first reported a position in Syndax Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • TD Asset Management's Syndax Pharmaceuticals position peaked at $732K in Q1 2024.
  • 196 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2024.

Based on TD Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.